Orthofix Medical Inc. Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net
Orthofix Medical Inc. (OFIX) reported Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net of $5.58 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet · last filed 2018-10-29
- Orthofix Medical Inc. other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2017-12-31 was $0.00.
- Orthofix Medical Inc. other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2017-09-30 was $0.00.
- Orthofix Medical Inc. other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2017-06-30 was $0.00.
- Orthofix Medical Inc. other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2017-03-31 was $5.58M.
- Orthofix Medical Inc. other than temporary impairment losses, investments, portion recognized in earnings, net for fiscal 2017 was $5.58M, a 104.80% increase from fiscal 2016.
- Orthofix Medical Inc. other than temporary impairment losses, investments, portion recognized in earnings, net for fiscal 2016 was $2.73M.
| Period end | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 3 month | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 6 month | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 9 month | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 derived: sum of 2 quarters · filed 2018-10-29 | $0.00 derived: sum of 3 quarters · filed 2018-10-29 | $5.58M 10-K · filed 2018-02-26 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $0.00 derived: sum of 2 quarters · filed 2018-10-29 | $5.58M 10-Q · filed 2018-10-29 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $5.58M 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | $5.58M 10-Q · filed 2018-04-30 | |||
| 2016-12-31 | $2.73M 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |